betaxolol has been researched along with Optic Nerve Diseases in 7 studies
Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this prospective randomized double-masked comparative case series, 34 patients having LASIK for myopia were randomly assigned to receive topical betaxolol 0." | 5.10 | Effect of laser in situ keratomileusis on optic nerve head topography and retinal nerve fiber layer thickness. ( Bowman, RW; Cavanagh, HD; Hertzog, L; McCulley, JP; Song, J; Whitson, JT, 2003) |
| "Four hundred sixteen subjects with ocular hypertension (intraocular pressure >/=22 and | 2.75 | The ability of short-wavelength automated perimetry to predict conversion to glaucoma. ( Colen, TP; Lemij, HG; Reus, NJ; van der Schoot, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Öhnell, H | 1 |
| Heijl, A | 3 |
| Brenner, L | 1 |
| Anderson, H | 1 |
| Bengtsson, B | 3 |
| Leske, MC | 2 |
| Yang, Z | 2 |
| van der Schoot, J | 1 |
| Reus, NJ | 1 |
| Colen, TP | 1 |
| Lemij, HG | 1 |
| Vainio-Jylhä, E | 1 |
| Vuori, ML | 1 |
| Nummelin, K | 1 |
| Whitson, JT | 1 |
| McCulley, JP | 1 |
| Cavanagh, HD | 1 |
| Song, J | 1 |
| Bowman, RW | 1 |
| Hertzog, L | 1 |
| Hyman, L | 1 |
| Dong, L | 1 |
| Morrison, JC | 1 |
| Nylander, KB | 1 |
| Lauer, AK | 1 |
| Cepurna, WO | 1 |
| Johnson, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optical Coherence Tomography Angiography Analysis of Macular and Papillary Perfusion After Variable Refractive Surgery Methods in Myopic Patients[NCT04424069] | 100 participants (Anticipated) | Interventional | 2020-03-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for betaxolol and Optic Nerve Diseases
| Article | Year |
|---|---|
Structural and Functional Progression in the Early Manifest Glaucoma Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Betaxolol; Combined Modality Therapy; Diagnostic Techn | 2016 |
Disc hemorrhages and treatment in the early manifest glaucoma trial.
Topics: Adrenergic beta-Antagonists; Betaxolol; Combined Modality Therapy; Disease Progression; Follow-Up St | 2008 |
The ability of short-wavelength automated perimetry to predict conversion to glaucoma.
Topics: Aged; Antihypertensive Agents; Betaxolol; Double-Blind Method; Female; Follow-Up Studies; Glaucoma; | 2010 |
Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Disease Progression; Double-Blind Method; Femal | 2002 |
Effect of laser in situ keratomileusis on optic nerve head topography and retinal nerve fiber layer thickness.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Cytoprotection; Double-Blind Method; Female; Hu | 2003 |
Predictors of long-term progression in the early manifest glaucoma trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Betaxolol; Blood Pressure; Cardiovascular Diseases | 2007 |
1 other study available for betaxolol and Optic Nerve Diseases
| Article | Year |
|---|---|
Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Clonidine; Disease Model | 1998 |